Table 4. CF-DNA quantity (ng) in relation to patient prognosis.
| Gene | Overall(n = 79) | Non-relapsed(n = 58) | Relapsed(n = 21) | p-value# |
|---|---|---|---|---|
| Median (iqr range) | Median (iqr range) | Median (iqr range) | ||
| HER2 LONG | 0.034 (0.011–0.137) | 0.032 (0.014–0.121) | 0.049 (0.007–0.137) | 0.868 |
| HER2 SHORT | 0.238 (0.093–0.509) | 0.206 (0.087–0.466) | 0.409 (0.123–0.890) | 0.078 |
| BCAS1 LONG | 0.266 (0.131–0.941) | 0.238 (0.093–0.798) | 0.292 (0.169–0.970) | 0.339 |
| BCAS1 SHORT | 1.269 (0.536–2.133) | 1.277 (0.525–2.275) | 1.269 (0.677–2.069) | 0.824 |
| MYC LONG | 0.421 (0.146–1.205) | 0.364 (0.164–1.379) | 0.485 (0.120–1.048) | 0.965 |
| MYC SHORT | 1.145 (0.557–2.255) | 1.136 (0.557–2.246) | 1.185 (0.689–2.255) | 0.689 |
| PI3KCA LONG | 0.108 (0.036–0.373) | 0.082 (0.032–0.315) | 0.195 (0.049–0.472) | 0.226 |
| PI3KCA SHORT | 1.619 (0.296–4.332) | 1.630 (0.251–3.198) | 1.619 (0.338–4.365) | 0.549 |
#Two-sample Wilcoxon rank-sum (Mann-Whitney) test.